多能干细胞作为一种临床前细胞模型,用于研究遗传性性偏症
Devid Damiani1, Matteo Baggiani1, Stefania Della Vecchia1,2
1Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione Stella Maris, Via dei Giacinti 2, 56128 Pisa, Italy.
International journal of molecular sciences
|March 13, 2024
概括
诱导多能干细胞 (iPS) 提供了一种强大的新方法来研究遗传性性护理 (HSP). 来自iPS细胞的患者衍生神经元有效地模拟HSP,有助于理解和开发治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 干细胞生物学 干细胞生物学
背景情况:
- 遗传性性 (HSP) 是一组影响皮质脊髓神经元轴突的神经退行性疾病.
- 目前的治疗方法是症状性的,对于HSP来说没有治疗方法.
- 传统的细胞和动物模型在预测治疗方法方面存在局限性.
研究的目的:
- 审查使用诱导多能干细胞 (iPS) 来产生患者特异的神经元用于HSP研究的最新文献.
- 评估患者衍生神经元作为体外模型的实用性,以了解HSP.
- 探索iPS细胞技术在开发HSP新治疗策略方面的潜力.
主要方法:
- 对利用患者衍生的iPS细胞用于HSP研究的研究的文献综述.
- 从免疫学和奥米克学方法对患者衍生神经元的研究结果的分析.
- 评估iPS细胞衍生神经元作为药物查平台.
主要成果:
- 来自iPS细胞的患者衍生神经元在体外忠实地模仿HSP.
- 这些模型促进了有关HSP病理生理学的新发现.
- 从iPS细胞衍生的神经元为选治疗药物提供了一个可行的平台.
结论:
- 来自患者的iPS细胞代表了HSP研究的重大进展.
- 这些模型对于扩大HSP的基本知识至关重要.
- 对于开发通用和个性化HSP治疗,iPS细胞技术具有前景.
更多相关视频
14:192D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
Published on: March 25, 2022
3.9K
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020
7.8K
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Embryonic Stem Cells
27.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
27.4K
